Recent developments with Zai Lab Limited ADR (ZLAB) have led to the company’s beta value being reach 1.12 cents.

Zai Lab Limited ADR (NASDAQ: ZLAB) kicked off on Tuesday, down -2.23% from the previous trading day, before settling in for the closing price of $27.38. Over the past 52 weeks, ZLAB has traded in a range of $13.48-$36.60.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 136.21% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 21.00%. With a float of $108.70 million, this company’s outstanding shares have now reached $108.94 million.

In an organization with 2175 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 63.17%, operating margin of -95.07%, and the pretax margin is -76.13%.

Zai Lab Limited ADR (ZLAB) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 0.21%, while institutional ownership is 44.80%. The most recent insider transaction that took place on Jul 01 ’24, was worth 133,455. In this transaction Director of this company sold 7,750 shares at a rate of $17.22, taking the stock ownership to the 60,778 shares. Before that another transaction happened on Dec 31 ’24, when Company’s insider sold 7,583 for $26.28, making the entire transaction worth $199,289. This insider now owns 33,834 shares in total.

Zai Lab Limited ADR (ZLAB) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 21.00% per share during the next fiscal year.

Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators

Take a look at Zai Lab Limited ADR’s (ZLAB) current performance indicators. Last quarter, stock had a quick ratio of 2.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.20.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.71 in one year’s time.

Technical Analysis of Zai Lab Limited ADR (ZLAB)

Let’s dig in a bit further. During the last 5-days, its volume was 0.71 million. That was better than the volume of 0.64 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 59.73%. Additionally, its Average True Range was 1.33.

During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 40.66%, which indicates a significant decrease from 65.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.27% in the past 14 days, which was lower than the 57.67% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $26.69, while its 200-day Moving Average is $22.33. However, in the short run, Zai Lab Limited ADR’s stock first resistance to watch stands at $27.89. Second resistance stands at $29.01. The third major resistance level sits at $29.66. If the price goes on to break the first support level at $26.11, it is likely to go to the next support level at $25.46. The third support level lies at $24.34 if the price breaches the second support level.

Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats

The company with the Market Capitalisation of 2.92 billion has total of 109,428K Shares Outstanding. Its annual sales at the moment are 266,720 K in contrast with the sum of -334,620 K annual income. Company’s last quarter sales were recorded 102,270 K and last quarter income was -41,670 K.